PCSK9 and atherosclerosis: Together with the finding that statin therapy induces PCSK9 expression, which could potentially limit the ability of statins to reduce LDL-C to very low levels (Dubuc et al., 2004), great interest in PCSK9 as potential treatment target in ASCVD prevention and treatment aroused.